BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10873679)

  • 1. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction.
    Saito T; Rodger IW; Hu F; Shennib H; Giaid A
    Biochem Biophys Res Commun; 2000 Jul; 273(2):772-5. PubMed ID: 10873679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of COX pathway in experimental myocardial infarction.
    Saito T; Rodger IW; Hu F; Robinson R; Huynh T; Giaid A
    J Mol Cell Cardiol; 2004 Jul; 37(1):71-7. PubMed ID: 15242737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor.
    Saito T; Rodger IW; Shennib H; Hu F; Tayara L; Giaid A
    Can J Physiol Pharmacol; 2003 Feb; 81(2):114-9. PubMed ID: 12710523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.
    Timmers L; Sluijter JP; Verlaan CW; Steendijk P; Cramer MJ; Emons M; Strijder C; Gründeman PF; Sze SK; Hua L; Piek JJ; Borst C; Pasterkamp G; de Kleijn DP
    Circulation; 2007 Jan; 115(3):326-32. PubMed ID: 17210840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
    Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
    LaPointe MC; Mendez M; Leung A; Tao Z; Yang XP
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1416-24. PubMed ID: 14670812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential pro-thrombotic effects of cyclooxygenase-2. inhibitors Two cases pf myocardial infarction].
    Thuaire C; Mankoubi L; Rangé G; Roussel L; Belfaqih H; el Khayef L; Belghit A; Charaf M; Albert F
    Arch Mal Coeur Vaiss; 2003 Jun; 96(6):683-5. PubMed ID: 12868352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study.
    Burdan F
    Toxicology; 2005 Jul; 211(1-2):12-25. PubMed ID: 15863244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure.
    Delgado RM; Nawar MA; Zewail AM; Kar B; Vaughn WK; Wu KK; Aleksic N; Sivasubramanian N; McKay K; Mann DL; Willerson JT
    Circulation; 2004 Mar; 109(11):1428-33. PubMed ID: 15023870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection.
    Ma N; Szabolcs MJ; Sun J; Albala A; Sciacca RR; Zhong M; Edwards N; Cannon PJ
    Transplantation; 2002 Dec; 74(11):1528-34. PubMed ID: 12490785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
    Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
    Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
    J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function.
    Xing W; Yan W; Fu F; Jin Y; Ji L; Liu W; Wang L; Lv A; Duan Y; Zhang J; Zhang H; Gao F
    Apoptosis; 2009 Sep; 14(9):1050-60. PubMed ID: 19590963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.